The Aβ Aggregation Pathway

Amyloid-beta peptides (primarily Aβ₄₀ and Aβ₄₂) are normal byproducts of the amyloid precursor protein (APP). In a healthy brain, these monomers are cleared away. In Alzheimer's, the clearance fails or production increases, triggering the following toxic cascade:

Monomers: Normal, individual peptides that naturally occur in the brain.
Oligomers: Small, soluble clusters of monomers. These are widely considered the most toxic species, as they can damage synapses and spread easily throughout the brain.
Protofibrils & Fibrils: Elongated, rope-like structures formed as oligomers clump together.
Amyloid Plaques: Large, insoluble deposits of fibrils that accumulate in the extracellular spaces of the brain's cerebral cortex

Visualizing and Measuring AB aggregation using IHC

Total Aβ / Monomers + Aggregates: Using 6E10 or 4G8. They recognize the primary linear sequence of human Aβ. They require harsh retrieval methods because aggregation typically buries these epitopes.
Fibrillar Aggregates & Plaques: Using conformation-specific antibodies such as OC or WO1. These target structural β-sheet epitopes rather than the linear amino acid sequence.
Soluble Oligomers (Pre-fibrillar): Using conformation-specific A11. It targets the early toxic oligomeric intermediates without cross-reacting with mature fibrils or monomers.

Larvae brain stained with beta-Amyloid antibody against the immunogen (1-43 amino acid)

Major Disaggregation and Clearance Pathways

To counter aggregate accumulation, the brain relies on specific biological mechanisms:

Microglial Phagocytosis and Exophagy: Microglia act as the brain's primary cleanup crew. Through phagocytosis, they internalize and degrade smaller aggregates via endosomal/lysosomal pathways. For larger, insoluble plaques, microglia perform digestive exophagy—releasing lysosomal enzymes into an acidic extracellular compartment to dissolve plaques.
Enzymatic Degradation: The brain utilizes specific proteases to hydrolyze and break down Aβ aggregates. Primary enzymes include Neprilysin, Insulin-Degrading Enzyme (IDE), and Endothelin-Converting Enzyme (ECE).
Perivascular Clearance (IPAD): Extracellular fluid and degraded aggregate fragments are cleared along intramural perivascular and basement membrane channels in arteries, eventually draining into the peripheral lymphatic system.

Alzheimer's Synapse, Sleep, EEG Markers.jpg

CSF biomarkers showing pathological progression of Alzheimer's Disease

Therapeutic Disaggregation Mechanisms

Monoclonal Antibodies: Therapies, such as lecanemab, target and neutralize specific Aβ protofibrils and oligomers, preventing further aggregation and facilitating immune-mediated clearance.
Molecular Chaperones and Small Molecules: Research is exploring endogenous chaperones (e.g., specific heat-shock proteins) and targeted small molecules that bind to the hydrophobic domains of fibrils, triggering structural destabilization and disaggregation.